##
||||Page|
|---|---|---|---|
|Reference LAdministrative||Information||
|Trustees'
Annual
Report|||2-3|
|Accountant's
Report||||
|Statement
of Financial|Activity|||
|Balance Sheet||||
|Notes to the Financial|Statements||7-12|
|||THE CHARLOTTE FRANCES MAY|FOUNDATION|
|---|---|---|---|
|||REFERENCE 8 ADMINISTRATIVE|INFORMATION|
|1.|TRUSTEES|DrJ H Davies||
|||Dr G J Connett||
|||Mr M H Brora||
|2.|CHARITY NUMBER|288386||
|3,|PRINCIPAL ADDRESS|1"Floor||
|||Chilworth
Point||
|||1 Chilworth
Road||
|||Southampton||
|||SO167JQ||
|4.|ACCOUNTANT|Rothmans
LLP||
|||Chartered
Accountants||
|||Chilworth
Point||
|||1 Chilworth
Road||
|||Southampton||
|||SO167JQ||
|5.|BANKERS|Coutts &Co||
|||440 Strand||
|||London||
|||WC2R OQS||
|6.|SOLICITOR|Paris Smith||
|||Number
1 London Road||
|||Southampton||
|||SO152AE||
##
##
##
##
##
##
##
##
##
|||2023|2023|2023|2022|2022|2022|
|---|---|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|||E|F|K||E|E|
|INCOME AND ENDOWMENTS||FROM;||||||
|Donations
and legacies|||23,800|23,800||1,550|1,550|
|Investments||1,529||1,529|36||36|
|TOTAL||||||||
|||1,529|23,800|25,329|36|1,550|1,586|
|EXPENDITURE ON:||||||||
|Charitable
activities|(Note 4)|5,567|7,346|12,913|1,057|11,505|12,562|
|TOTAL||||||||
|||5,567|7,346|12,913|1,057|11,505|12,562|
|NET INCOME/(EXPENDITURE)||(4,039)|16,454|12,416|(1,021)|(9,955)|(10,976)|
|NET MOVEMENT|IN FUNDS|(4,039)|16,454|12,416|(1,021)|(9,955)|(10,976)|
|RECONCILIATION|OF FUNDS|||||||
|TOTAL FUNDS||||||||
|BROUGHT FORWARD||123,638|245,326|368,964|124,659|255,281|379,940|
|TOTAL FUNDS||||||||
|CARRIED FORWARD||119,599|261,781|381,380|123,638|245,326|368,964|
##
||||2023|2023|2023|2022|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||Funds|Funds|Funds|Funds|
|||Note|F|f|f||
|Current Asset|||||||
|Cash at bank and|in hand||120,164|263,016|383,180|370,764|
|Liabilities|||||||
|Creditors:
falling due within one year||8|(564)|(1,236)|(1,800)|(1,800)|
|Total net assets|||119,599|261,781|381,380|368,964|
|THE FUNDS OF|THE CHARITY||||||
|Unrestricted
fund|||119,599||119,599|123,638|
|Restricted
funds||||261,781|261,781|245,326|
|TOTAL CHARITY|FUNDS||119,599|261,781|381,380|368,964|
##
##
##
##
##
##
##
##
##
##
|3.
DONATION|S|AND LEGA|CIES|||||
|---|---|---|---|---|---|---|---|
||||||2023||2022|
||||||K|||
|General
Donations||||||23,800|1,550|
|Total donations
and||legacies||||23,800|1,550|
|4.
ANALYSIS|OF CHARITABLE ACTIVITIES|||||||
|Research, Education||and Resourcing||Costs|Support|costs|Total|
|2023||||||||
|Diabetic||||774||134|908|
|Bursledon
House||||3,643||630|4,274|
|Paediatric
Neurology||||900||156|1,056|
|Genetic Research||||386||67|453|
|Paediatric Gastroenterology||||909||157|1,067|
|Ready Steady Go||||733||127|859|
|General
and Founders||||3,663||633|4,296|
|Total expenditure|on|Charitable|Activities|11,009||1,904|12,913|
|2022||||||||
|Cystic Fibrosis||||4,122||379|4,501|
|Diabetic||||306||28|334|
|Bursledon
House||||2,084||191|2,275|
|Paediatric
Long Term||Ventilation||900||83|983|
|Ready Steady Go||||4,093||376|4,469|
|General and Founders||||||||
|Total expenditure|on|Charitable|Activities|11,505||1,057|12,562|
##
##
##
##
|Governance|and|Support costs|Support
costs|Governance
costs|Total|
|---|---|---|---|---|---|
||||E|||
|2023||||||
|Administration|of|the charity|1,899||1,899|
|Bank charges|||5||5|
|Total expenditure||on Support Costs|1,904||1,904|
|2022||||||
|Administration|of|the charity|1,050||1,050|
|Bank charges|||7||7|
|Total expenditure||on Support Costs|1,057||1,057|
##
|CREDITORS: Amounts
falling due withi|n one year||
|---|---|---|
||2023|2022|
||E|E|
|Accruals|1,800|1,800|
|Total|1,800|1,800|
##
|. ANAL|YSIS OF|FUND ASSETS AND L|IABILITIES|||
|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|
||||Funds|Funds|Funds|
||||E|E|E|
|2023||||||
|Current|assets|||||
|Cash at|bank and|in hand|120,134|263,016|383,150|
|Current|liabilities|||||
|Creditors|and accruals||(565)|(1,235)|(1,800)|
||||119,569|261,781|381,350|
|2022||||||
|Current|assets|||||
|Cash at|bank and|in hand|124,421|246,523|370,944|
|Current|liabilities|||||
|Creditors|and accruals||(603)|(1,197)|(1,800)|
||||123,638|245,326|369,144|
##
##
##
|||||||Other direct|||
|---|---|---|---|---|---|---|---|---|
|||||||charitable|General||
||||Balance at|Donations|Investme-nt|expendit-|administra-|Balance at|
|2023|||6 April 2022|received|income|ure|tion costs|5April 2023|
|||||||F|||
|Cystic Fibrosis|||4,553|||||4,553|
|Diabetic|||68,558|||(774)||67,784|
|Neonatal|||4,724|||||4,724|
|Paediatric|Neurology||37,673|||(900)||36,773|
|Bursledon|House||47,499|||(3,643)||43,856|
|Asthma|||3,016|||||3,016|
|Nephrology|||33,537|||||33,537|
|Genetic Research|||15,150|||(386)||14,764|
|Infantile
Deafness|||17,112|||||17,112|
|Paediatric|Gastroenterology||1,621|||(909)||712|
|Paediatric|Long Term|Ventilation|3,554|||||3,554|
|Society for Paediatric||Urological|||||||
|Surgeons (SPUS) 2013|||||||||
|Paediatric|Sleep Fund||856|||||856|
|Ready Steady Go|||7,473|23,800||(733)||30,540|
|Total Restricted
Funds|||245,326|23,800||~7,346)||261,781|
|||||||Other direct|||
|||||||charitable|General||
||||Balance at|Donations|Investme-nt|expendit-|administra-|Balance at|
|2022|||6 April 2021|received|income|ure|tion costs|5April 2022|
|||||E|E|F||F|
|Cystic Fibrosis|||8,675|||(4, 122)||4,553|
|Diabetic|||68,814|50||(307)||68,558|
|Neonatal|||4,724|||||4,724|
|Paediatric|Neurology||37,673|||||37,673|
|Bursledon|House||49,583|||(2,084)||47,499|
|Asthma|||3,016|||||3,016|
|Nephrology|||33,537|||||33,537|
|Genetic Research|||15,150|||||15,150|
|Infantile
Deafness|||17,112|||||17,112|
|Paediatric|Gastroenterology||1,621|||||1,621|
|Paediatric|Long Term|Ventilation|4,454|||(900)||3,554|
|Society for Paediatric||Urological|||||||
|Surgeons|(SPUS)2013||||||||
|Paediatric|Sleep Fund||356|500||||856|
|Ready Steady Go|||10,565|1,000||(4,092)||7,473|
|Total Restricted
Funds|||255,281|1,550||(11,505)||245,326|
##
##
##
|||||||Other direct|||
|---|---|---|---|---|---|---|---|---|
|||||||charitable|Gcncral||
||||Balance at|Donations|Investme-nt|expendit-|administra-|Balance at|
|2023|||6 April 2022
f|received
f|income
f|ure|tion costs
f|5 April 2023
f|
|Unrestricted
Funds
Total Unrestricted||Funds|123,638
123,638||1,529
1,529|(3,663)
(3,663)|(1,904)
~),964)|119,599
119,599|
|||||||Other direct|||
|||||||charitable|General||
||||Balance at|Donations|Investme-nt|expendit-|administra-|Balance at|
|2022|||6 April 2021
f|received
f|income
f|ure
f|tion costs
f|5 April 2022
f|
|Unrestricted|Funds||124,659||36||2|124,697|
|Total Unrestricted||Funds|124,659||36||2|124,697|